Genmab A (GMAB) Current Assets (2023 - 2025)
Historic Current Assets for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to $2.9 billion.
- Genmab A's Current Assets fell 2602.56% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year decrease of 2602.56%. This contributed to the annual value of $2.9 billion for FY2025, which is 2602.56% down from last year.
- Latest data reveals that Genmab A reported Current Assets of $2.9 billion as of Q4 2025, which was down 2602.56% from $4.5 billion recorded in Q3 2025.
- Over the past 5 years, Genmab A's Current Assets peaked at $4.9 billion during Q4 2023, and registered a low of -$335.0 million during Q1 2024.
- For the 3-year period, Genmab A's Current Assets averaged around $3.4 billion, with its median value being $3.9 billion (2024).
- Within the past 5 years, the most significant YoY rise in Genmab A's Current Assets was 130507.46% (2025), while the steepest drop was 2602.56% (2025).
- Genmab A's Current Assets (Quarter) stood at $4.9 billion in 2023, then dropped by 20.6% to $3.9 billion in 2024, then decreased by 26.03% to $2.9 billion in 2025.
- Its Current Assets was $2.9 billion in Q4 2025, compared to $4.5 billion in Q3 2025 and $3.9 billion in Q2 2025.